CompanyGraph
At a glance
- Depends onDownstream position: depends on 18 industries, supplies 6
- ScaleMarket cap is $142.46M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 0.66: distress zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
142.46MUSDvs all stocks (USD)
Revenue (TTM)
46.86MUSDvs all stocks (USD)
Beta
0.3230xvs all stocks
52-Week Change
-86.96%vs all stocks
Market Capitalization
142.46MUSDvs all stocks (USD)
Enterprise Value
153.20MUSDvs all stocks (USD)
Forward P/E
1.09xPrice to Sales (TTM)
3.09xPrice to Book (MRQ)
0.5299xEnterprise to Revenue
3.27xEnterprise to EBITDA
-3.38xGross Margin
42.85%Operating Margin
-393.87%Return on Assets (TTM)
-21.23%Return on Equity (TTM)
-108.43%Revenue (TTM)
46.86MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.1050USDUpdated Sep 27, 2026Quarterly Revenue Growth
287.10%Gross Profit (TTM)
33.28MUSDvs all stocks (USD)
EBITDA (TTM)
-45.30MUSDvs all stocks (USD)
Net Income (TTM)
-173.47MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
287.15%Operating Cash Flow (TTM)
-90.74MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-124.23MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 27, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
39.09MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
8.69MUSDFY2025 · Dec 31, 2025Gross Profit
30.40MUSDFY2025 · Dec 31, 2025Operating Income
-32.48MUSDvs all stocks (USD)
Pre-tax Income
-78.99MUSDFY2025 · Dec 31, 2025Income Tax Expense
5.00KUSDFY2025 · Dec 31, 2025Net Income
-78.99MUSDFY2025 · Dec 31, 2025EBIT
-32.48MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-16.35MUSDFY2025 · Dec 31, 2025Research & Development
16.50MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
46.38MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.5200USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.5200USDFY2025 · Dec 31, 2025Basic Shares Outstanding
152.58MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
152.58MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-78.99MUSDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00USDFY2025 · Dec 31, 2025Operating Cash Flow
-53.70MUSDFY2025 · Dec 31, 2025Free Cash Flow
-54.08MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.00MUSDFY2025 · Dec 31, 2025Income Tax Paid
4.00KUSDFY2025 · Dec 31, 2025Interest Paid
874.00KUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-78.99MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
10.34MUSDFY2025 · Dec 31, 2025Stock-based Compensation
6.26MUSDFY2025 · Dec 31, 2025Other Non-cash Items
22.93MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-31.95MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
7.44MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
10.28MUSDFY2025 · Dec 31, 2025Capital Expenditures
-380.00KUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
0.00USDFY2025 · Dec 31, 2025Net Acquisitions
-7.50MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-7.88MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
27.53MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-4.26MUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-1.32MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
0.00USDFY2025 · Dec 31, 2025Other Financing Charges
2.50MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
29.47MUSDFY2025 · Dec 31, 2025Shares Outstanding
855.56MSharesUpdated Sep 27, 2026Float Shares
679.52MSharesUpdated Sep 27, 2026Shares Short
120.47MSharesUpdated Sep 27, 2026Short Ratio
1.98daysvs all stocks
Short % of Shares Outstanding
17.10%vs all stocks
% Held by Insiders
27.85%vs all stocks
% Held by Institutions
6.33%vs all stocks
Total Cash (MRQ)
1.40MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.0010USDUpdated Sep 27, 2026Total Debt (MRQ)
9.67MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0393xCurrent Ratio (MRQ)
4.95xBook Value per Share (MRQ)
0.2880USDUpdated Sep 27, 2026Total Assets
274.70MUSDvs all stocks (USD)
Total Current Assets
142.87MUSDFY2025 · Dec 31, 2025Total Liabilities
36.73MUSDFY2025 · Dec 31, 2025Total Non-current Assets
131.83MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
9.85MUSDFY2025 · Dec 31, 2025Total Current Liabilities
26.88MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.00MUSDFY2025 · Dec 31, 2025Accounts Receivable
888.00KUSDFY2025 · Dec 31, 2025Inventory
636.00KUSDFY2025 · Dec 31, 2025Accounts Payable
10.83MUSDFY2025 · Dec 31, 2025Short-term Debt
5.59MUSDFY2025 · Dec 31, 2025Deferred Revenue
1.88MUSDFY2025 · Dec 31, 2025Long-term Debt
5.92MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
3.92MUSDFY2025 · Dec 31, 2025Common Stock (Book)
59.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-377.44MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
237.97MUSDvs all stocks (USD)
52-Week Low
0.1400USDUpdated Sep 27, 202652-Week High
4.10USDUpdated Sep 27, 202652-Week Change
-86.96%vs all stocks
Beta
0.3230xvs all stocks
50-Day MA
0.2858USDUpdated Sep 27, 2026200-Day MA
0.5845USDUpdated Sep 27, 2026Avg 10-Day Volume
77.16MSharesUpdated Sep 27, 2026Avg 30-Day Volume
62.77MSharesUpdated Sep 27, 2026Diluted EPS (TTM)
0.0300USDUpdated Sep 27, 2026Other Income / Expense
-26.53MUSDFY2025 · Dec 31, 20253 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Diagnostic
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
Where is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 4.95Altman Z-Score: 0.66
Financial Health
Altman Z-Score 0.66: distress zoneCritical
Altman Z-Score: 0.66
Supply Chain
Downstream position: depends on 18 industries, supplies 6Notable
Outgoing: 6.00Incoming: 18.00
High connectivity hub: 24 industry connectionsNotable
Total Connections: 24.00
Scale
Market cap is $142.46M, lower than 95% of all stocks globallySignificant
Market cap (USD): 142,459,300Global P5: 275,556,405.438
Companies that share the same coordination system — how they create, deliver, or capture value.
Exodus Movement, Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceRisk
Beeks Financial Cloud Group PLC
Tier 1FlowRecurring-Revenue Lock-InProductionInterface
Kusurinomadoguchi Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
Spok Holdings Inc.
Tier 1FlowRecurring-Revenue Lock-InProductionInterface
Danal Co. Ltd.
Tier 1FlowRecurring-Revenue Lock-InInterfaceRisk
Zaggle Prepaid Ocean Services Ltd.
Tier 1FlowRecurring-Revenue Lock-InRiskInterface
Fonix PLC
Tier 1FlowRecurring-Revenue Lock-InInterfaceRisk
Blend Labs Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
Hennge K.K.
Tier 1FlowRecurring-Revenue Lock-InRuleProduction
MTI Ltd.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Voronoi, Inc.
3 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
D&D Pharmatech Inc.
3 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Veritone, Inc.
3 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC